BRD7 increases resistance to EGFR tyrosine kinase inhibitor (EGFR-TKI) in non-small cell lung cancer
Minerva Med
.
2021 Sep 3.
doi: 10.23736/S0026-4806.21.07716-8.
Online ahead of print.
Authors
Haiping Zhang
1
,
Li Zhang
2
,
Jianfang Xu
3
Affiliations
1
Department of Oncology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.
2
Department of Respiratory and Critical Care Medicine, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.
3
Department of Oncology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China - xujianfang63@aliyun.com.
PMID:
34477353
DOI:
10.23736/S0026-4806.21.07716-8
No abstract available